| P2860 | cites work | Pharmacodynamics and clinical use of guanethidine, bretylium and methyldopa | Q78953796 |
| | Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension | Q79039993 |
| | Methyldopa in the treatment of hypertension | Q79343779 |
| | Effect of alpha-methyl DOPA in severe and malignant hypertension | Q79362280 |
| | Another hypotensive agent--methyldopa | Q79373644 |
| | Methyldopa in hypertension. Clinical and pharmacological studies | Q79378613 |
| | Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension | Q79396482 |
| P433 | issue | 5310 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 984-984 | |
| P577 | publication date | 1962-10-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | To-day's Drugs | |
| P478 | volume | 2 | |